Narcolepsy Treatments Are Advancing. Can Access?
Race, age, and other factors are linked to disparities in care for people with narcolepsy.
The gold-standard assay for measuring orexin deficiency in cerebrospinal fluid requires a lumbar puncture and radioactive materials. New findings could help advance testing alternatives for people with narcolepsy.
Cognitive symptoms have largely been absent from narcolepsy clinical trials. New research defines these symptoms and illustrates their impact, with researchers hoping they will be included moving forward.
The increased offer values Avadel at up to approximately $2.37 billion.
A phase 3 trial is underway to evaluate the drug's efficacy and safety in adults with IH, with enrollment expected to complete by the end of 2025.
A new study found that 85% of active duty servicemen and servicewomen have sleep disorders.
An experienced non-profit leader and author is appointed to the first-ever professional staff role for the foundation.